Skip to content

Quick ratio at other companies

IAR
Integra LifeSciencesIART
+1.2×
MiMedx Group logo
MiMedx GroupMDXG
4.8×+0.7×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
1.8×+0.3×
Bioventus logo
BioventusBVS
1.1×+0.2×
Artivion logo
ArtivionAORT
2.8×-1.2×
Axogen logo
AxogenAXGN
5.3×+2.7×

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Based on the most recent quarter.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s quick ratio?
Organogenesis Holdings Inc. (ORGO) reported quick ratio of 3.2× in Q1 2026.
How has Organogenesis Holdings Inc.'s quick ratio changed year-over-year?
Organogenesis Holdings Inc.'s quick ratio decreased by 14.0% year-over-year, from 3.7× to 3.2×.
What is the long-term trend for Organogenesis Holdings Inc.'s quick ratio?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s quick ratio has grown at a 9.1% compound annual growth rate (CAGR), from 2.1× to 3.3×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.